ENTITY

Dynavax Technologies (DVAX US)

5
Analysis
Health Care • United States
Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.
more
Exchange Announcement • 10 Feb 2026 22:10

Current Report (Form 8-K | Period ending 2026-02-10)

Exchange Announcement • 29 Dec 2025 20:35

SC14D9C | Written communication by the subject company relating to a third party tender offer

Exchange Announcement • 29 Dec 2025 20:33

SC14D9C | Written communication by the subject company relating to a third party tender offer

Exchange Announcement • 29 Dec 2025 20:31

Current Report (Form 8-K | Period ending 2025-12-23)

Exchange Announcement • 06 Nov 2025 05:08

Quarterly Report (Form 10-Q | Period ending 2025-09-30)

x